Filtros de búsqueda

Lista de obras de Srinivasan Madhusudan

5-Carboxylcytosine levels are elevated in human breast cancers and gliomas

artículo científico publicado en 2015

A multicenter Phase I gene therapy clinical trial involving intraperitoneal administration of E1A-lipid complex in patients with recurrent epithelial ovarian cancer overexpressing HER-2/neu oncogene.

artículo científico publicado en 2004

A multicentre phase II trial of bryostatin-1 in patients with advanced renal cancer.

artículo científico publicado en 2003

A phase II study of etanercept (Enbrel), a tumor necrosis factor alpha inhibitor in patients with metastatic breast cancer.

artículo científico publicado en 2004

A prospective randomised phase II trial of thalidomide with carboplatin compared with carboplatin alone as a first-line therapy in women with ovarian cancer, with evaluation of potential surrogate markers of angiogenesis

artículo científico publicado en 2011

ATM Regulated PTEN Degradation Is XIAP E3 Ubiquitin Ligase Mediated in p85α Deficient Cancer Cells and Influence Platinum Sensitivity

artículo científico publicado en 2019

Acquired resistance to temozolomide in glioma cell lines: molecular mechanisms and potential translational applications.

artículo científico publicado en 2010

Adverse prognostic and predictive significance of low DNA-dependent protein kinase catalytic subunit (DNA-PKcs) expression in early-stage breast cancers

artículo científico publicado en 2014

Analysis of lymphatic and blood vessel invasion biomarkers in T1 esophagogastric adenocarcinomas for improved patient prognostication.

artículo científico publicado en 2014

Are DNA repair factors promising biomarkers for personalized therapy in gastric cancer?

artículo científico publicado en 2012

Ataxia telangiectasia mutated and Rad3 related (ATR) protein kinase inhibition is synthetically lethal in XRCC1 deficient ovarian cancer cells

artículo científico publicado en 2013

Base excision repair factors are promising prognostic and predictive markers in cancer.

artículo científico

Bcl2 is an independent prognostic marker of triple negative breast cancer (TNBC) and predicts response to anthracycline combination (ATC) chemotherapy (CT) in adjuvant and neoadjuvant settings

artículo científico publicado en 2013

Biological and clinical significance of PARP1 protein expression in breast cancer

artículo científico publicado en 2014

Camptothecin targets WRN protein: mechanism and relevance in clinical breast cancer

artículo científico publicado en 2016

Cancer pharmacogenomics: role of DNA repair genetic polymorphisms in individualizing cancer therapy.

artículo científico publicado en 2007

Caspase-cleaved cytokeratin-18 and tumour regression in gastro-oesophageal adenocarcinomas treated with neoadjuvant chemotherapy.

artículo científico publicado en 2012

Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial

artículo científico publicado en 2015

Certain imidazotetrazines escape O6-methylguanine-DNA methyltransferase and mismatch repair.

artículo científico publicado en 2011

Checkpoint kinase1 (CHK1) is an important biomarker in breast cancer having a role in chemotherapy response

artículo científico publicado en 2015

Chk1 phosphorylated at serine345 is a predictor of early local recurrence and radio-resistance in breast cancer

artículo científico publicado en 2015

Circulating biomarkers during treatment in patients with advanced biliary tract cancer receiving cediranib in the UK ABC-03 trial

artículo científico publicado en 2018

Clinical Impact of Tumor DNA Repair Expression and T-cell Infiltration in Breast Cancers

artículo científico publicado en 2017

Clinical and biological significance of RAD51 expression in breast cancer: a key DNA damage response protein

artículo científico publicado en 2016

Clinicopathological and Functional Significance of RECQL1 Helicase in Sporadic Breast Cancers

artículo científico publicado en 2016

Clinicopathological and functional significance of XRCC1 expression in ovarian cancer

artículo científico publicado en 2012

Clinicopathological and prognostic significance of RECQL5 helicase expression in breast cancers.

artículo científico publicado en 2015

Clinicopathological significance of ATM-Chk2 expression in sporadic breast cancers: a comprehensive analysis in large cohorts.

artículo científico publicado en 2014

Clinicopathological significance of KU70/KU80, a key DNA damage repair protein in breast cancer

artículo científico publicado en 2013

Clinicopathological significance of ataxia telangiectasia-mutated (ATM) kinase and ataxia telangiectasia-mutated and Rad3-related (ATR) kinase in MYC overexpressed breast cancers

scientific article published on 12 February 2019

Clinicopathological significance of human apurinic/apyrimidinic endonuclease 1 (APE1) expression in oestrogen-receptor-positive breast cancer

artículo científico publicado en 2014

Current status of excision repair cross complementing-group 1 (ERCC1) in cancer.

artículo científico publicado en 2007

DNA Repair Endonucleases: Physiological Roles and Potential as Drug Targets.

artículo científico

DNA damage repair in breast cancer and its therapeutic implications

artículo científico publicado en 2016

DNA polymerase β deficiency is linked to aggressive breast cancer: a comprehensive analysis of gene copy number, mRNA and protein expression in multiple cohorts

artículo científico publicado en 2014

DNA repair in cancer: emerging targets for personalized therapy.

scientific article published on 19 February 2014

DNA repair inhibition: a selective tumour targeting strategy.

artículo científico publicado en 2005

DNA repair prognostic index modelling reveals an essential role for base excision repair in influencing clinical outcomes in ER negative and triple negative breast cancers

artículo científico publicado en 2015

Development and evaluation of human AP endonuclease inhibitors in melanoma and glioma cell lines

artículo científico publicado en 2011

Dissecting DNA repair in adult high grade gliomas for patient stratification in the post-genomic era.

artículo científico publicado en 2014

Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial

artículo científico publicado en 2013

Dysregulation of human apurinic/apyrimidinic endonuclease 1 (APE1) expression in advanced retinoblastoma.

artículo científico publicado en 2014

ERCC1 Is a Predictor of Anthracycline Resistance and Taxane Sensitivity in Early Stage or Locally Advanced Breast Cancers

artículo científico publicado en 2019

ERCC1-XPF deficiency is a predictor of olaparib induced synthetic lethality and platinum sensitivity in epithelial ovarian cancers

artículo científico publicado en 2019

Efficacy and toxicity of the angiogenesis inhibitor SU5416 as a single agent in patients with advanced renal cell carcinoma, melanoma, and soft tissue sarcoma.

artículo científico publicado en 2003

Evaluation of CDK12 Protein Expression as a Potential Novel Biomarker for DNA Damage Response-Targeted Therapies in Breast Cancer.

artículo científico publicado en 2017

Evolving drug targets in DNA base excision repair for cancer therapy

artículo científico publicado en 2012

Expression of the calpain system is associated with poor clinical outcome in gastro-oesophageal adenocarcinomas.

artículo científico publicado en 2013

Feasibility of Intravenous Iron Isomaltoside to Improve Anemia and Quality of Life During Palliative Chemotherapy for Esophagogastric Adenocarcinoma

scientific article published on 10 September 2018

Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial.

artículo científico publicado en 2014

Genomic and protein expression analysis reveals flap endonuclease 1 (FEN1) as a key biomarker in breast and ovarian cancer

artículo científico publicado en 2014

HER-2/Neu overexpression is a rare event in peri-ampullary cancer: assessment using the HercepTest.

artículo científico publicado en 2009

Human AP endonuclease 1 (APE1): from mechanistic insights to druggable target in cancer.

artículo científico publicado en 2010

Human Helicase RECQL4 Drives Cisplatin Resistance in Gastric Cancer by Activating an AKT-YB1-MDR1 Signaling Pathway.

artículo científico publicado en 2016

Human apurinic/apyrimidinic endonuclease (APE1) is a prognostic factor in ovarian, gastro-oesophageal and pancreatico-biliary cancers.

artículo científico publicado en 2010

Inherited variants in the MC1R gene and survival from cutaneous melanoma: a BioGenoMEL study

artículo científico publicado en 2012

Intrahepatic sarcomatoid cholangiocarcinoma.

artículo científico publicado en 2010

Intraperitoneal gene therapy.

artículo científico publicado en 2007

Is there a role for base excision repair in estrogen/estrogen receptor-driven breast cancers?

artículo científico publicado en 2014

Is there a role for second-line platinum re-challenge in advanced biliary tract cancers?

artículo científico publicado en 2014

Isolation of a small molecule inhibitor of DNA base excision repair.

artículo científico publicado en 2005

KPNA2 is a nuclear export protein that contributes to aberrant localisation of key proteins and poor prognosis of breast cancer

artículo científico publicado en 2015

LY2495655, an antimyostatin antibody, in pancreatic cancer: a randomized, phase 2 trial

scientific article published on 27 July 2018

MAGIC in practice: experience of peri-operative ECF/X chemotherapy in gastro-esophageal adenocarcinomas.

artículo científico publicado en 2012

MYC functions are specific in biological subtypes of breast cancer and confers resistance to endocrine therapy in luminal tumours.

artículo científico publicado en 2016

Monoclonal Antibodies Targeting LecLex-Related Glycans with Potent Antitumor Activity.

artículo científico publicado en 2015

Oncogenic osteomalacia and metastatic breast cancer: a case report and review of the literature

artículo científico publicado en 2019

PARP1 blockade is synthetically lethal in XRCC1 deficient sporadic epithelial ovarian cancers

artículo científico publicado en 2019

Pharmacokinetically guided phase I trial of topotecan and etoposide phosphate in recurrent ovarian cancer

artículo científico publicado en 2005

Phase I study of MetXia-P450 gene therapy and oral cyclophosphamide for patients with advanced breast cancer or melanoma.

artículo científico publicado en 2005

Phase II trial of the antiangiogenic agent IM862 in metastatic renal cell carcinoma

artículo científico publicado en 2004

Postoperative survival following perioperative MAGIC versus neoadjuvant OE02-type chemotherapy in oesophageal adenocarcinoma

artículo científico publicado en 2017

Primary Esophagogastric Neuroendocrine Carcinoma: a Retrospective Study from the Nottingham Upper Gastrointestinal Cancer Center.

artículo científico publicado en 2017

Purification and specific assays for measuring APE-1 endonuclease activity.

artículo científico publicado en 2012

Quality of life, long-term survivors and long-term outcome from the ABC-02 study

artículo científico publicado en 2016

RAD50 deficiency is a predictor of platinum sensitivity in sporadic epithelial ovarian cancers

artículo científico publicado en 2020

RECQL4 helicase has oncogenic potential in sporadic breast cancers

artículo científico publicado en 2015

Reply, Letter to the Editor - The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma

SUMOylation proteins in breast cancer

artículo científico publicado en 2014

Screening for malnutrition: implications for upper gastrointestinal cancer services

scientific article published on 01 October 2010

Single-strand selective monofunctional uracil-DNA glycosylase (SMUG1) deficiency is linked to aggressive breast cancer and predicts response to adjuvant therapy

artículo científico publicado en 2013

Study of etanercept, a tumor necrosis factor-alpha inhibitor, in recurrent ovarian cancer

artículo científico publicado en 2005

Synthetic lethal targeting of DNA double-strand break repair deficient cells by human apurinic/apyrimidinic endonuclease inhibitors

artículo científico publicado en 2012

Targeting BRCA1-BER deficient breast cancer by ATM or DNA-PKcs blockade either alone or in combination with cisplatin for personalized therapy

artículo científico publicado en 2014

Targeting XRCC1 deficiency in breast cancer for personalized therapy.

artículo científico publicado en 2012

Targeting ataxia telangiectasia-mutated- and Rad3-related kinase (ATR) in PTEN-deficient breast cancers for personalized therapy

artículo científico publicado en 2018

Targeting human apurinic/apyrimidinic endonuclease 1 (APE1) in phosphatase and tensin homolog (PTEN) deficient melanoma cells for personalized therapy ⬇️

artículo científico publicado en 2014

The ataxia telangiectasia mutated kinase pathway regulates IL-23 expression by human dendritic cells

artículo científico publicado en 2013

The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma

artículo científico publicado en 2015

The presence of tumour-associated lymphocytes confers a good prognosis in pancreatic ductal adenocarcinoma: an immunohistochemical study of tissue microarrays.

artículo científico publicado en 2013

The relationship of CDK18 expression in breast cancer to clinicopathological parameters and therapeutic response

artículo científico publicado en 2018

The role of adjuvant platinum-based chemotherapy in esophagogastric cancer patients who received neoadjuvant chemotherapy prior to definitive surgery.

artículo científico publicado en 2017

Thioredoxin interacting protein and its association with clinical outcome in gastro-oesophageal adenocarcinoma

artículo científico publicado en 2013

Transcriptomic and Protein Expression Analysis Reveals Clinicopathological Significance of Bloom Syndrome Helicase (BLM) in Breast Cancer.

artículo científico publicado en 2015

Transcriptomic profiling of Forkhead box transcription factors in adult glioblastoma multiforme

artículo científico publicado en 2015

Tumour regression grade (TRG) analyses in patients with resectable gastro-oesophageal adenocarcinomas treated with platinum-based neoadjuvant chemotherapy.

artículo científico publicado en 2009

Tyrosine kinase inhibitors and cancer therapy.

artículo científico publicado en 2007

Untangling the ATR-CHEK1 network for prognostication, prediction and therapeutic target validation in breast cancer

artículo científico publicado en 2014

Untangling the clinicopathological significance of MRE11-RAD50-NBS1 complex in sporadic breast cancers

artículo científico publicado en 2021

Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase 2 trial.

artículo científico publicado en 2017

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda